These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27671045)

  • 1. [Changes of menstruation patterns and adverse effects during the treatment of LNG-IUS for symptomatic adenomyosis].
    Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):657-662. PubMed ID: 27671045
    [No Abstract]   [Full Text] [Related]  

  • 2. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
    Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
    Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Liu ZZ; You SS; Chang XY; Lang YH
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2415-20. PubMed ID: 27545034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
    Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
    Li L; Leng J; Jia S; Lang J
    Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
    Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
    Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
    Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
    Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.
    Hai N; Hou Q; Guo R
    Int J Hyperthermia; 2021; 38(1):65-69. PubMed ID: 33472465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies for pelvic pain associated with adenomyosis.
    Radzinsky VE; Khamoshina MB; Nosenko EN; Dukhin AO; Sojunov MA; Orazmuradov AA; Lebedeva MG; Orazov MR
    Gynecol Endocrinol; 2016 Oct; 32(sup2):19-22. PubMed ID: 27759444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
    Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
    Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
    Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
    Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis.
    Lee YL; Bai YS; Yu MH; Chang FW; Wang YC; Chiang KJ; Wu GJ; Yin CS
    Taiwan J Obstet Gynecol; 2024 Jul; 63(4):492-499. PubMed ID: 39004475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
    Zheng J; Xia E; Li TC; Sun X
    J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
    Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
    J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
    Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
    Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.